Gene Expression Market by Product and Services (Consumables (Reagents, DNA chips), Instruments (PCR, NGS, DNA, Microarray, Others), Services (Gene Expression Profiling, Bioinformatics Solutions)), End User (Pharma and Biotech Companies, Research Centers, Others) And Geographic Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa): Industry Trends and Global Forecasts, 2023-2032

Gene Expression Market Size and Overview

 The gene expression market size is poised to reach USD 21.3 billion by the end of 2032, growing at a CAGR of 8.8 % during the forecast period, i.e., 2023 – 2032. In the year 2022, the industry size of gene expression market was USD 9.2 billion. The reason behind the growth can be attributed to the increasing popularity of precision medicine and personalized treatment options, advancements in technology, growing demand for gene expression analysis in disease diagnosis and treatment, expansion of institutions and research centers in developing regions and increasing adoption of generation sequencing (NGS) technologies. The marketplace incorporates a wide range of products, along with services. The market is highly competitive with key players striving to meet evolving customer demands.

Gene Expression Market Segmentation

By Products & Services

• Consumables
  • Reagents
  • DNA Chips
• Instruments
  • PCR
  • NGS
  • DNA Microarray
  • Others
• Services
  • Gene Expression Profiling Services
    • Sequencing Services
    • Other Services
  • Bioinformatics Solutions

By End User

• Pharmaceutical and Biotech companies
• Academic Institutes and Research Centers
• Others

By Geographic 

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of products & services in the gene expression market the instruments segment accounted the highest market share in 2022. The instruments section holds the biggest marketplace share within the gene expression marketplace. This may be attributed to the increasing demand for superior technologies and automation in gene expression evaluation. With the developing recognition of precision medicinal drug and customized treatment alternatives, the demand for high-throughput gene expression analysis is predicted to witness steady boom. Additionally, advancements in era, such as single-cell analysis, are in addition fueling the growth capacity of this section.

Gene Expression Market Regional Analysis

North America stands as one of the major markets for gene expression, driven through the well-established healthcare infrastructure. Additionally, emphasis on precision medicine and personalized treatment options in healthcare contributes make contributions to the region’s dominance. The United States, primarily, is a key contributor on this marketplace. Europe is one of the leading marketplaces for gene expression because of the region’s mix of academic and research institutes, pharmaceutical and biotechnology companies, and hospitals and diagnostic centers. The European market showcases a growing interest in gene expression analysis for disease diagnosis and treatment. The Asia Pacific gene expression market is estimated to witness significant growth, during the forecast timeframe led by, rapid economic growth, increasing healthcare expenditure, and a growing focus on research and development. The demand for gene expression is anticipated to rise in countries like China and India, in which expanding pharmaceutical and biotechnology industries and rising popularity of precision medicine. Latin America and the Middle East and Africa display steady growth inside the gene expression market, fueled via urban development, a rising middle class, and a growing demand for advanced healthcare services and increasing research and development activities in these regions. Key participants to the market's growth in these areas encompass Brazil, Mexico, the United Arab Emirates, and South Africa.

Gene Expression Market Growth Drivers

The increasing popularity of precision medicine and personalized treatment options is driving the need, for gene expression analysis technologies. Moreover, advancements in technology have resulted in the creation of throughput and single cell gene expression analysis methods attracting the interest of researchers and healthcare professionals. This growing demand for gene expression analysis in disease diagnosis and treatment is contributing to market growth. The rising adoption of gene expression analysis in drug discovery and development holds potential for growth. Pharmaceutical and biotechnology companies rely on gene expression analysis to identify and validate targets, test drug efficacy and screen for toxicity. The shift towards precision medicine and personalized treatments aligns with the increasing focus on patient centered healthcare. The expansion of institutions and research centers in developing regions is driving the demand for gene expression analysis. Research activities require gene expression analysis to understand disease mechanisms identify targets and develop treatments. This boost in sales includes instruments, reagents and services. The increasing adoption of generation sequencing (NGS) technologies has allowed genes to be sequenced quickly and efficiently compared to traditional methods. As a result, the cost of gene expression analysis has decreased, making it more accessible, to researchers and clinicians.

Gene Expression Market Challenges

High cost of gene expression analysis and complex data analysis are hindering the growth of market. In developing regions, this factor has resulted in limited demand for product. Moreover, the lack of standardized protocols is also restricting the growth of market.

Gene Expression Market Key Companies

 The gene expression market is poised by several main corporations, each making big contributions to the industry through their sturdy market presence and progressive product offerings. Among these principal players are Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Roche, PerkinElmer, Qiagen, QIAGEN N.V., Oxford Gene Technologies, Eurofins Scientific And other players. These essential players constantly try and revamp their marketplace percentage and meet the desires of a diverse investor base. Their competitive techniques encompass product innovation, forging strategic partnerships, undertaking mergers and acquisitions, and increasing their distribution networks.

In January 2023, Illumina Launched the NovaSeq 9600, a next-generation sequencing (NGS) platform that can sequence up to 9600 samples simultaneously.

In March 2023, Thermo Fisher Scientific Acquired Life Sciences International, a provider of gene expression analysis products and services.